Wholesalers in Japan had a good year last year. The biggest firms like Medipal may prosper but there are challenges for the sector which could result in more M&A and a squeeze on profits.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.